Results 11 to 20 of about 44,168 (180)

Travertine crystal growth ripples record the hydraulic history of ancient Rome’s Anio Novus aqueduct

open access: yesScientific Reports, 2022
Travertine crystal growth ripples are used to reconstruct the early hydraulic history of the Anio Novus aqueduct of ancient Rome. These crystalline morphologies deposited within the aqueduct channel record the hydraulic history of gravity-driven ...
Duncan Keenan-Jones   +6 more
doaj   +1 more source

Ahora nos ven

open access: yesCuadernos de Antropología Social, 2022
En este artículo analizamos algunas obras artísticas exhibidas y producidas en el marco de dos eventos públicos que tuvieron como objetivo recordar el incendio de interfase urbano-forestal del 9 de marzo de 2021 en el noroeste del Chubut.
María Alma Tozzini   +1 more
doaj   +1 more source

Spatial and temporal patterns of drought in the Continental U.S. during the past century

open access: yesGeophysical Research Letters, 2016
This study investigates the spatial and temporal patterns of multiple drought characteristics (duration, severity, and intensity) under different return periods during 1900–2012 in the Continental U.S. (CONUS). We find two significant patterns: Pattern I
Yan Ge, Tushar Apurv, Ximing Cai
doaj   +1 more source

Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML

open access: yesBiomarker Research, 2023
KMT2A-rearranged acute myeloid leukemia (KMT2Ar-AML) is an aggressive subtype of AML with poor response and prognosis. KMT2Ar-AML has been demonstrated to be sensitive to BCL2 inhibitor venetoclax (VEN), but these patients are unable to benefit from ...
Qing Ling   +13 more
doaj   +1 more source

Climatic and terrestrial storage control on evapotranspiration temporal variability: Analysis of river basins around the world

open access: yesGeophysical Research Letters, 2016
Knowledge of the temporal variability of evapotranspiration (ET) is fundamental to a comprehensive understanding of hydroclimatologic processes under a changing climate and anthropogenic interferences.
Ruijie Zeng, Ximing Cai
doaj   +1 more source

Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)

open access: yesHaematologica, 2020
Venetoclax (Ven), an orally administered, potent BCL-2 inhibitor, has demonstrated efficacy in chronic lymphocytic leukemia (CLL) in combination with rituximab (R) or obinutuzumab (G). Our aim was to investigate the addition of bendamustine (B) to these
Stephan Stilgenbauer   +15 more
doaj   +1 more source

Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia

open access: yesBiomarker Research, 2021
Venetoclax (VEN) plus azacitidine has become the first-line therapy for elderly patients with acute myeloid leukemia (AML), and has a complete remission (CR) plus CR with incomplete recovery of hemogram rate of ≥70%.
Xiang Zhang   +8 more
doaj   +1 more source

Hydropower versus irrigation—an analysis of global patterns

open access: yesEnvironmental Research Letters, 2017
Numerous reservoirs around the world provide multiple flow regulation functions; key among these are hydroelectricity production and water releases for irrigation.
Ruijie Zeng   +3 more
doaj   +1 more source

A retrospective comparison of salvage intensive chemotherapy venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML)

open access: yesTherapeutic Advances in Hematology, 2022
Background: Evidence that a venetoclax (VEN)-combined regimen is effective in relapsed/refractory acute myeloid leukemia (R/R AML) is emerging. However, it is unknown how VEN-combined low intensity treatment compares to intensive chemotherapy (IC) in ...
Silvia Park   +19 more
doaj   +1 more source

Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia

open access: yesFrontiers in Oncology, 2023
BackgroundSatisfactory responses can be obtained for acute myeloid leukemia (AML) treated by Venetoclax (VEN)-based therapy. However, there are still quite a few AML patients (AMLs) resistant to VEN, and it is critical to understand whether VEN ...
Peng Ke   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy